Communiqués CTT Pharmaceutical Holdings, Inc.

Actions

CTTH

US12651E1064

Recherche biotechnologique et médicale

Marché Fermé - OTC Markets 21:59:43 04/09/2026			Varia. 5j.	Varia. 1 janv.
0,0485 ^USD	-3,06%		-3,00%	-19,31%

12/08	CTT Pharmaceutical Holdings, Inc. obtient l'homologation d'un brevet aux États-Unis pour sa technologie d'administration de nicotine, de vitamines et de caféine	CI
29/05	CTT Pharmaceutical Holdings, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Communiqués

18/08	CTT Pharma Files a Patent Continuation with the U.S. Patent Office	AQ
12/08	CTT Pharma Corporate Updates	AQ
10/08	CTT Pharma Receives U.S. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery Technology	AQ
05/08	CTT Pharma Receives SEC Approval	AQ
22/06	CTT Pharma Signs LOI for Clinical Trials and Testing of Nicotine Products	AQ
17/06	CTT Pharma Signs LOI with European Company	AQ
14/05	CTT Pharma Signs LOI with European Company	AQ
02/12	CTT Pharma CEO Issues Letter to Shareholders	AQ
20/11	CTT Pharma's CEO will issue a Letter to Shareholders	AQ
10/09/25	CTT Pharma Signs Contract for $3 Million Equity Line of Credit	AQ
10/06/25	CTT Pharma Grant Updates	AQ
12/03/25	CTT Pharma's CEO Issues Letter to Shareholders	AQ
22/01/25	CTT Pharma has engaged The OTC Markets to Uplist to The OTCQB	AQ
07/01/25	CTT Pharma and Johns Hopkins University Submits Proposal For $15 Million NIH Grant For Smoking Cessation	AQ
29/10/24	CTT Pharma's CEO Speaks at FDA and NIH Meeting for Advancing Smoking Cessation	AQ
21/08/24	CTT Pharmaceuticals Holdings, Inc. Successfully Completes 2 Year PCAOB Audit	AQ
15/07/24	CTT Pharmaceuticals Holdings, Inc. Signs Contract for 2 year PCAOB Audit	AQ
25/06/24	CTT Pharma Gives Update on NSF Grant for Smoke Reduction Technology	AQ
27/03/24	CTT Pharma Partners with Johns Hopkins University for NIH Grant for a Smoking Cessation Product	AQ
28/03/23	CTT Pharma Appoints David Paton as Senior Advisor	AQ
30/01/23	CTT Pharma Corporate Updates	AQ
19/12/22	CTT Pharma Updates On Worldwide Patent Portfolio	AQ
06/12/22	CTT Pharma Receives Approval for European Patent	AQ
30/11/22	CTT Pharma Starts Product Development	AQ
22/11/22	CTT Pharma Signs Agreement for New Oral Products	AQ